NORFOLK AND WAVENEY STP THERAPEUTICS ADVISORY GROUP (TAG) SHARED CARE AGREEMENTNorfolk And • March 26th, 2024
Contract Type FiledMarch 26th, 2024Shared care guidelines for Oral and Subcutaneous Methotrexate for various indications – full details shown on page 2Monitoring level - AMBER Level 3 – Prescribe the drug and perform significant monitoring including measurements such as height, weight, blood pressure and ECG. Monthly monitoring is necessary Generic and Proprietary/Brand Name MethotrexateTablets: Matrex® - generics also availablePre-filled pens: Metoject® 50mg/ml strength, and Nordimet® 25mg/ml strength;Pre-filled syringes: Zlatal® 25mg/ml strength – generic pre-filled syringes also availableRegarding injection devices: the product that the patient has been initially trained on should not be changed without adequate retraining on an alternative device. It is recommended to confirm with the patient which product is being used to ensure continuity of care Indications for shared care • Treatment of rheumatoid arthritis, juvenile idiopathic arthritis, connective tissue disease, Felty's Syndrome, psoriasis, Crohn’s disease